Diving Into The World Of HBOT
Get the latest news and research on Hyperbaric Oxygen Therapy, also known as HBOT. Hyperbaric Oxygen Therapy involves breathing 100% oxygen under pressure while in a hyperbaric chamber, and is used to treat an extensive list of conditions involving tissue damage and inflammation.
Subscribe below to receive updates on the latest HBOT related news & research, as well as personal interviews & stories from researchers, practitioners, and patients who’ve found hope in HBOT. Stay tuned as we dive into the phenomenon that is Hyperbaric Oxygen Therapy.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or watch an episode here on the HBOT News:
Special Report – A Medical Revolution
Explore the profound benefits of HBOT in treating various health conditions, focusing on its anti-inflammatory and healing properties.
Recent News & Research
Resolving TBI’s and Suicide Hailed as Most Important Scientific Breakthrough for 2019 Oxygen Under Pressure (HBOT) – Read Why Medical Studies Have Proven This Works
Durham, NC (January 15, 2020) - Congressman Andy Biggs (AZ-05) and Senator Kevin Cramer (R-ND) recently introduced the TBI and PTSD Treatment Act [House Bill 4370; Senate Bill 2504], in late 2019 to direct the Veterans Administration (VA) to...
Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.
HBOT for Infertility = Creation of a Baby Friendly Environment
This article originally appeared on WoundReference. Introduction We have previously discussed the rationale for using hyperbaric oxygen therapy (HBOT) in an “off-label” indication. We suggested that there must be a scientific rationale, physiology...
Dying for a cure
CINCINNATI (WKRC) - Suicide among our members of the military and our veterans is now at its highest level ever, reaching an average of 24 deaths a day. Several scientific and medical studies link many of these suicides to physical brain damage...
Hyperbaric oxygen therapy benefits in concussion management
Many Oklahomans suffer from debilitating conditions resulting from head trauma. Brain injuries may result from active duty military service, sports activities, automobile accidents, and from a host of other traumatic events. State Rep. Jay Steagall...
Hyperbaric oxygen therapy may relieve symptoms of side-effects of radiotherapy: Study
Oxygen in the hyperbaric chamber provides relief after radiotherapy, new research has found. Radiotherapy is part of many treatment protocols of cancer in organs such as the prostate, cervix, ovaries, and colon and it may cause several side-effects...
The Nobel Prize in Physiology or Medicine 2019 – Sensing oxygen levels
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.
Fargo VA to offer hyperbaric oxygen therapy for vets as part of pilot program
Other four facilities in the program have a 100% success rate in helping brain wounds for veteransHEALING UNDER PRESSURE: HYPERBARIC OXYGEN THERAPY (HBOT) CLINICAL DEMONSTRATION EXPANDS TO TWO MORE SITESVeterans in South-Central Texas and Central...
Micheal Bear Clair HBOT Story
Michael Bear Clair is a former Professional wrestler and Nashville Session player and lifelong touring musician. He spent his teen years and adult life playing music for a living and playing with some of the biggest stars in the music industry...